


INNATE PHARMA : Sanofi et Innate Pharma étendent leur collaboration pour le développement de NK Cell engagers en oncologie

EVERZOM et OmniSpirant annoncent le lancement du projet INSPIRE pour le développement d’une thérapie génique inédite délivrée par aérosol pour traiter le cancer du poumon

Enterome completes patient enrollment of Phase 2
ROSALIE study evaluating its lead immunotherapy,
EO2401, in recurrent glioblastoma

DOMAIN THERAPEUTICS strengthens Scientific Advisory Board with appointment of immuno-oncology experts
